California El Camino Real Association of Occupational Health Nurses
Stay Connected

COVID-19 and Occupational Medicine

Posted over 1 year ago in COVID 19

University of Washington presents: COVID-19 and Occupational Medicine 

February 4, 2021, 6:30-8:00pm 

For registration or more information about the event, please visit the event site:

Featured Speakers 

Eric J. Chow, MD, MS, MPH, FACP, FAAP   

Infection Disease Fellow University of Washington, Allergy & Infectious Diseases  

 Hee Yon Sohng, MD, MPH   

Physician, Occupational & Environmental Medicine Kaiser-Permanente, Seattle  

Geralyn L. McClendon, RN, BSN   

Occupational Nurse Consultant Manager and External OMD Consultant Contract Manager Office of the Medical Director, Department of Labor & Industries   

 Course moderated by Ann Tu, MD, MPH   

Clinical Assistant Professor, University of Washington, Occupational & Environmental Medicine  

Lecture Overview

Over the past few months, evidence has mounted about serious long-term effects of infection. Patients--many of whom have recovered from mild to moderate disease--report symptoms that persist or even develop after the initial viral infection, and are often relapsing and remitting in nature. In one recent report, 60% of recovered noncritical patients studied had persistent symptoms 3 months after discharge*.   

With daily increases in the number of cases in the US and worldwide, it is likely that the number of people experiencing long-term symptoms will also continue to grow. Important considerations for the occupational medicine practitioner include: how this syndrome impacts return to work decisions, and claims management if the initial viral disease is work-related.   

 During this lecture, Dr. Chow will describe the post-viral syndrome—what is known and what is theorized, what is being studied, and potential treatment strategies using a multidisciplinary and integrated approach. Dr. Sohng will present some cases from her occupational medicine practice.   

The panel, including Ms. McClendon, will be available for a participatory discussion with the audience.  


Continuing education for the activity has been approved. 

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. 

Please see for complete information on the types of continuing education.